Lysophosphatidic Acid and its Receptors LPA and LPA Mediate Paclitaxel-Induced Neuropathic Pain in Mice
Background: Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors (LPA 1 and LPA 3 ) are required for the initiation of peripheral nerve injury-...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2014-11-01
|
| Col·lecció: | Molecular Pain |
| Accés en línia: | https://doi.org/10.1186/1744-8069-10-71 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|